Kenneth J Kelley Halozyme Therapeutics, Inc. (HALO) insider trading activity

Kenneth J Kelley is Director of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 179,833 shares of HALO, which is worth approximately $8.44 Million. The most recent transaction as insider was on Apr 14, 2021, when has been sold 5,000 shares (Common Stock) at a price of $45.0 per share, resulting in proceeds of $225,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 180K

0% 3M change

0% 12M change

Total Value Held $8.44 Million

Kenneth J Kelley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 14 2021	SELL Open market or private sale	$225,000 $45.0 p/Share	5,000 Reduced 2.71%	179,833 Common Stock
Mar 01 2021	SELL Open market or private sale	$228,350 $45.67 p/Share	5,000 Reduced 2.63%	184,833 Common Stock
Feb 01 2021	SELL Open market or private sale	$241,950 $48.39 p/Share	5,000 Reduced 2.57%	189,833 Common Stock
Jan 04 2021	SELL Open market or private sale	$215,650 $43.13 p/Share	5,000 Reduced 2.5%	194,833 Common Stock
Dec 07 2020	SELL Open market or private sale	$1,438,526 $41.0 p/Share	35,086 Reduced 14.94%	199,833 Common Stock
Dec 02 2020	SELL Open market or private sale	$1,303,472 $41.0 p/Share	31,792 Reduced 11.92%	234,919 Common Stock
Nov 27 2020	SELL Open market or private sale	$412,500 $41.25 p/Share	10,000 Reduced 3.61%	266,711 Common Stock
Nov 25 2020	SELL Open market or private sale	$401,346 $41.5 p/Share	9,671 Reduced 3.38%	276,711 Common Stock

KJK

Kenneth J Kelley

Director

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Value

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO

Account